The Washington Post

PharmedOUT in The Washington Post:

• June 9, 2023: Alzheimer’s drug Leqembi backed by FDA advisers for full approval By Laurie McGinley 

• October 17, 2022: FDA wants to yank pregnancy drug. Firm argues Black women will suffer By Ariana Eunjung Cha. 

• August 23, 2020: Opinion: Rushing convalescent plasma therapy for covid-19 isn't wise By Adriane-Fugh-Berman

• December 6, 2019: Inside the opioid industry’s marketing machine By Sari Horwitz, Scott Higham, Dalton Bennett and Meryl Kornfield 

• October 30, 2019: Vaping companies like mint, but not for the flavor By Adriane Fugh-Berman

• July 29, 2017: Doctors often don’t tell you about drug side effects, and that’s a problem By Janice Neumann

• November 14, 2016: Why is that salesman in the operating room for your knee replacement? By Sandra G. Boodman

• October 16, 2016: The drug industry's answer to opioid addiction: More pills By Ariana Eunjung Cha

• July 5, 2016: Pfizer agrees to truth in opioid marketing By Lenny Bernstein

• June 14, 2016: How drug companies use gifts and internships to buddy up to their most valuable patients By Carolyn Y. Johnson

• December 21, 2015: Homeopathic drugs: No better than placebos? By Consumer Reports

• August 18, 2015: FDA approves controversial drug for women with low sex drives By Brigid Schuite and Brady Dennis

• January 12, 2015: C-Section: my rights, my body, my baby By Dr. Anthony Scialli

• May 27, 2013: Hot flashes and hormones: A complex issue By Gisela Telis

• March 12, 2012: Antipsychotic drugs grow more popular for patients without mental illness By Sandra G. Boodman and Kaiser Health news

• May 22, 2007: Doctors, Legislators Resist Drugmakers' Prying Eyes By Christopher Lee

• April 29, 2007: Drugmakers, Doctors Get Cozier By Christopher Lee

• January 23, 2007: Hold the Hors d'Oeuvres: Program Helps Doctors Stay Current Without Accepting Drugmakers’ Meals By Sandra G. Boodman